ORAMED PHARMACEUTICALS INC. 4
4 · ORAMED PHARMACEUTICALS INC. · Filed Mar 14, 2016
Insider Transaction Report
Form 4
JACOB HAROLD
Director
Transactions
- Sale
Common Stock
2016-03-10$6.45/sh−8,500$54,842→ 16,396 total
Holdings
- 700(indirect: By wholly-owned corporation)
Common Stock
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.41 to $6.54, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the above range.